News

MP-376 is a proprietary aerosolized formulation of the antibiotic levofloxacin that is being developed for the treatment of chronic lung infections due to pseudomonas aeruginosa in CF patients.

Ceftobiprole, an anti-MRSA antibiotic, was granted fast track designation by the FDA. The regulatory dossiers were submitted by Basilea’s co-development partner Johnson & Johnson in the US and

Under the terms of the agreement, Dompe will manufacture PRX321 at its facility in Italy for the upcoming pre-pivotal clinical trial and has committed to supply commercial batches

The company plans to report its annual 2007 results along with the new product business units. Crucell has appointed Mr Bjorn Sjostrand to head the vaccines business unit.

The company will now enter lead optimization as it continues to progress towards development. As a result of this identification, Pharmacopeia will receive a $500,000 milestone payment from

70 patients took part in the 52 week trial in Europe and Canada. Although interim analysis of patients in this trial at 36 weeks suggested a trend toward

The initial focus of the collaboration is to pursue treatments for orphan diseases of the mitochondria – the cellular energy center. Under the terms of the agreement, Penwest

Lipitor’s global revenue fell by 13% to $2.7 billion due to lower US demand and changes in wholesaler inventories, according to Pfizer. Compared with 2006, the company expects

US researchers compared 10 diabetes pills and found they all worked well to reduce blood sugar levels. The Glucophage drug, which costs about $100 a year, came out